Evidence map›Paper›PMID 39185011›Full record

ArticleAJOG global reports2024

A tale of two societies: implications of conflicting Rh-immunoglobulin guidelines.

Cara Heuser, Rachel Flink-Bochacki, Jeffrey Sperling, Katharine Simmons, Kirsten Salmeen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in AJOG global reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cara HeuserDivisions of MFM and CFP, Intermountain Health and University of Utah, Salt Lake City, Utah (Heuser).
Rachel Flink-BochackiDivision of CFP, Albany Medical Center, Albany NY (Flink-Bochacki).
Jeffrey SperlingDepartment of Obstetrics and Gynecology, Divisions of MFM and CFP, Kaiser Permanente, Modesto CA (Sperling, Simmons, Salmeen).
Katharine SimmonsDepartment of Obstetrics and Gynecology, Divisions of MFM and CFP, Kaiser Permanente, Modesto CA (Sperling, Simmons, Salmeen).
Kirsten SalmeenDepartment of Obstetrics and Gynecology, Divisions of MFM and CFP, Kaiser Permanente, Modesto CA (Sperling, Simmons, Salmeen).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

National guidance conflicts regarding the use of RhD immune globulin administration <12w. Recent Society for Maternal Fetal Medicine (SMFM) guidelines suggest liberal use of this product while other guidelines, including Society of Family Planning and the World Health Organization, propose a more conservative approach. Medicine is not practiced in a vacuum, and potential harms must include not only individual but communal and public health effects. We aim to critically examine the practical implications of the new SMFM guidelines with a focus on equity and access.

Indexed as

alloimmunizationisoimmunizationRhD immune globulin

Identifiers

PMID39185011
PMCPMC11342755

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.